vs
ボシュ・ヘルス（BHC）とPost Holdings, Inc.（POST）の財務データ比較。上の社名をクリックして会社を切り替えられます
ボシュ・ヘルスの直近四半期売上が大きい（$2.8B vs $2.2B、Post Holdings, Inc.の約1.3倍）。Post Holdings, Inc.の純利益率が高く（4.5% vs -3.7%、差は8.1%）。Post Holdings, Inc.の前年同期比売上増加率が高い（10.1% vs 9.3%）。ボシュ・ヘルスの直近四半期フリーキャッシュフローが多い（$403.0M vs $119.3M）。過去8四半期でボシュ・ヘルスの売上複合成長率が高い（14.0% vs 4.3%）
ボシュ・ヘルス・カンパニーズ・インクはカナダと米国に拠点を置くグローバルな多角的製薬企業で、グローバル本社はカナダ・ケベック州ラヴァル、米国本社はニュージャージー州ブリッジウォーターに所在します。消化器科、肝臓科、神経科、皮膚科、歯科、美容医療などの分野で医薬品の開発・製造・販売を行い、先発医薬品と後発医薬品の両方を取り扱っています。
Post Holdings, Inc.はアメリカの代表的な包装消費財食品メーカーで、主力事業にPost Consumer Brandsを有し、本社はミネソタ州レイクビルに所在します。同社が製造する各種食品は北米を中心に世界各国で販売され、多くの消費者に支持されています。
BHC vs POST — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $2.8B | $2.2B |
| 純利益 | $-103.0M | $96.8M |
| 粗利率 | — | 29.4% |
| 営業利益率 | 17.0% | 11.0% |
| 純利益率 | -3.7% | 4.5% |
| 売上前年比 | 9.3% | 10.1% |
| 純利益前年比 | -205.1% | -14.6% |
| EPS（希薄化後） | $-0.30 | $1.71 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $2.8B | $2.2B | ||
| Q3 25 | $2.7B | $2.2B | ||
| Q2 25 | $2.5B | $2.0B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.6B | $2.0B | ||
| Q3 24 | $2.5B | $2.0B | ||
| Q2 24 | $2.4B | $1.9B | ||
| Q1 24 | $2.2B | $2.0B |
| Q4 25 | $-103.0M | $96.8M | ||
| Q3 25 | $179.0M | $51.0M | ||
| Q2 25 | $148.0M | $108.8M | ||
| Q1 25 | $-58.0M | $62.6M | ||
| Q4 24 | $98.0M | $113.3M | ||
| Q3 24 | $-85.0M | $81.6M | ||
| Q2 24 | $10.0M | $99.8M | ||
| Q1 24 | $-64.0M | $97.2M |
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 26.8% | ||
| Q2 25 | — | 30.0% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | — | 28.6% | ||
| Q2 24 | — | 29.6% | ||
| Q1 24 | — | 29.0% |
| Q4 25 | 17.0% | 11.0% | ||
| Q3 25 | 23.1% | 7.5% | ||
| Q2 25 | 17.5% | 11.8% | ||
| Q1 25 | 12.2% | 9.3% | ||
| Q4 24 | 21.8% | 10.8% | ||
| Q3 24 | 12.7% | 9.5% | ||
| Q2 24 | 16.2% | 10.4% | ||
| Q1 24 | 13.1% | 9.5% |
| Q4 25 | -3.7% | 4.5% | ||
| Q3 25 | 6.7% | 2.3% | ||
| Q2 25 | 5.8% | 5.5% | ||
| Q1 25 | -2.6% | 3.2% | ||
| Q4 24 | 3.8% | 5.7% | ||
| Q3 24 | -3.4% | 4.1% | ||
| Q2 24 | 0.4% | 5.1% | ||
| Q1 24 | -3.0% | 4.9% |
| Q4 25 | $-0.30 | $1.71 | ||
| Q3 25 | $0.48 | $0.91 | ||
| Q2 25 | $0.40 | $1.79 | ||
| Q1 25 | $-0.16 | $1.03 | ||
| Q4 24 | $0.24 | $1.78 | ||
| Q3 24 | $-0.23 | $1.28 | ||
| Q2 24 | $0.03 | $1.53 | ||
| Q1 24 | $-0.17 | $1.48 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $1.3B | $279.3M |
| 総負債低いほど良い | $20.8B | $7.5B |
| 株主資本純資産 | $-554.0M | $3.5B |
| 総資産 | $26.4B | $13.0B |
| 負債/資本比率低いほどレバレッジが低い | — | 2.16× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $1.3B | $279.3M | ||
| Q3 25 | $1.3B | $176.7M | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.1B | $617.6M | ||
| Q4 24 | $1.2B | $872.9M | ||
| Q3 24 | $719.0M | $787.4M | ||
| Q2 24 | $595.0M | $333.8M | ||
| Q1 24 | $733.0M | $333.4M |
| Q4 25 | $20.8B | $7.5B | ||
| Q3 25 | $21.0B | $7.4B | ||
| Q2 25 | $21.7B | $7.3B | ||
| Q1 25 | $21.5B | $6.9B | ||
| Q4 24 | $21.6B | $6.9B | ||
| Q3 24 | $21.5B | $6.8B | ||
| Q2 24 | $21.7B | $6.4B | ||
| Q1 24 | $22.1B | $6.4B |
| Q4 25 | $-554.0M | $3.5B | ||
| Q3 25 | $-565.0M | $3.8B | ||
| Q2 25 | $-764.0M | $4.0B | ||
| Q1 25 | $-1.2B | $3.8B | ||
| Q4 24 | $-1.3B | $3.9B | ||
| Q3 24 | $-1.2B | $4.1B | ||
| Q2 24 | $-1.2B | $3.9B | ||
| Q1 24 | $-1.1B | $4.0B |
| Q4 25 | $26.4B | $13.0B | ||
| Q3 25 | $26.8B | $13.5B | ||
| Q2 25 | $27.3B | $13.4B | ||
| Q1 25 | $26.4B | $12.8B | ||
| Q4 24 | $26.5B | $12.8B | ||
| Q3 24 | $26.5B | $12.9B | ||
| Q2 24 | $26.5B | $12.1B | ||
| Q1 24 | $26.9B | $12.2B |
| Q4 25 | — | 2.16× | ||
| Q3 25 | — | 1.98× | ||
| Q2 25 | — | 1.84× | ||
| Q1 25 | — | 1.81× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.62× | ||
| Q1 24 | — | 1.61× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $495.0M | $235.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $403.0M | $119.3M |
| FCFマージンFCF / 売上 | 14.4% | 5.5% |
| 設備投資強度設備投資 / 売上 | 3.3% | 5.4% |
| キャッシュ転換率営業CF / 純利益 | — | 2.43× |
| 直近12ヶ月FCF直近4四半期 | $1.0B | $436.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $495.0M | $235.7M | ||
| Q3 25 | $405.0M | $301.3M | ||
| Q2 25 | $289.0M | $225.9M | ||
| Q1 25 | $211.0M | $160.7M | ||
| Q4 24 | $601.0M | $310.4M | ||
| Q3 24 | $405.0M | $235.4M | ||
| Q2 24 | $380.0M | $272.3M | ||
| Q1 24 | $211.0M | $249.6M |
| Q4 25 | $403.0M | $119.3M | ||
| Q3 25 | $314.0M | $151.6M | ||
| Q2 25 | $190.0M | $94.9M | ||
| Q1 25 | $96.0M | $70.2M | ||
| Q4 24 | $495.0M | $171.4M | ||
| Q3 24 | $334.0M | $96.2M | ||
| Q2 24 | $302.0M | $161.5M | ||
| Q1 24 | $129.0M | $150.9M |
| Q4 25 | 14.4% | 5.5% | ||
| Q3 25 | 11.7% | 6.7% | ||
| Q2 25 | 7.5% | 4.8% | ||
| Q1 25 | 4.2% | 3.6% | ||
| Q4 24 | 19.3% | 8.7% | ||
| Q3 24 | 13.3% | 4.8% | ||
| Q2 24 | 12.6% | 8.3% | ||
| Q1 24 | 6.0% | 7.5% |
| Q4 25 | 3.3% | 5.4% | ||
| Q3 25 | 3.4% | 6.7% | ||
| Q2 25 | 3.9% | 6.6% | ||
| Q1 25 | 5.1% | 4.6% | ||
| Q4 24 | 4.1% | 7.0% | ||
| Q3 24 | 2.8% | 6.9% | ||
| Q2 24 | 3.2% | 5.7% | ||
| Q1 24 | 3.8% | 4.9% |
| Q4 25 | — | 2.43× | ||
| Q3 25 | 2.26× | 5.91× | ||
| Q2 25 | 1.95× | 2.08× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 6.13× | 2.74× | ||
| Q3 24 | — | 2.88× | ||
| Q2 24 | 38.00× | 2.73× | ||
| Q1 24 | — | 2.57× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
BHC
| Bausch Lomb | $1.4B | 50% |
| Salix Segment | $693.0M | 25% |
| International Rx | $306.0M | 11% |
| Diversified Segment | $255.0M | 9% |
| Solta Medical Segment | $137.0M | 5% |
POST
| Post Consumer Brands Segment | $1.1B | 51% |
| Pet Food | $360.4M | 17% |
| Side Dishes | $221.5M | 10% |
| Weetabix | $137.9M | 6% |
| Other | $122.1M | 6% |
| Nut Butters | $105.8M | 5% |
| Sausage | $53.1M | 2% |
| Cheeseand Dairy | $41.3M | 2% |
| Protein Based Shakes | $29.3M | 1% |
| Bell Ring | $18.1M | 1% |
